Moderna Has Halted Trial of a New mRNA Vaccine for Young People Following a Suspected Case of Myocarditis.
According to Stéphane Bancel, Chief Executive Officer of Moderna in January 2022 “EBV is one of the most common viral infections in the world, despite the fact that it causes infectious mononucleosis, which impacts millions of adolescents globally, no vaccine is currently available.” The Moderna …
Read More